(0.09%) 5 522.00 points
(0.13%) 39 897 points
(0.19%) 19 789 points
(-0.06%) $81.58
(0.57%) $2.83
(-0.23%) $2 339.10
(0.17%) $29.58
(0.45%) $1 006.30
(0.06%) $0.932
(-0.02%) $10.53
(0.03%) $0.788
(-0.85%) $87.25
2.13% $ 7.20
Live Chart Being Loaded With Signals
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology...
Stats | |
---|---|
Dzisiejszy wolumen | 85 473 |
Średni wolumen | 82 054 |
Kapitalizacja rynkowa | 132.16M |
EPS | $-0.250 ( Q1 | 2024-05-07 ) |
Następna data zysków | ( $-0.260 ) 2024-08-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-5.11 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0110 (0.15%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-13 | Kaplan Matthew L. | Buy | 30 000 | Common Stock |
2024-06-13 | Hoberman Kenneth | Buy | 30 000 | Common Stock |
2024-06-13 | Oliviero James F Iii | Buy | 30 000 | Common Stock |
2024-05-14 | Bentsur Ron | Buy | 1 940 | Common Stock |
2024-05-10 | Bentsur Ron | Buy | 2 000 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 100 transactions |
Buy: 1 141 381 | Sell: 0 |
Wolumen Korelacja
Nuvectis Pharma, Inc. Korelacja
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Nuvectis Pharma, Inc. Korelacja - Waluta/Towar
Nuvectis Pharma, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-22.90M (0.00 %) |
EPS: | $-1.430 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-22.90M (0.00 %) |
EPS: | $-1.430 |
FY | 2022 |
Przychody: | $149 000 |
Zysk brutto: | $-19.09M (-12 808.72 %) |
EPS: | $-1.480 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.091 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej